All posts tagged
This UK Biotech uses CRISPR-Cas9 Against Bacterial Resistance
Art Made with CRISPR Aims to Raise Awareness of Antibiotic Resistance
The Most Important Battle in Gene Editing: CRISPR versus TALEN
Europe Turns the Tables in the CRISPR Patent Battle
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
Allergan makes a deal with Editas to License CRISPR Programs for Eye Disease
More News! Is CRISPR better than TALEN for CAR-T?
More News! Will BMS be acquired? “CRISPR babies aren’t unethical”?
The Patent Office has Spoken: What does it Mean for CRISPR in Europe?
The UK Steps Up its Game in Automated CRISPR Gene Editing
Europe’s Lag in the Gene Editing Race may leave its Biotech Obsolete
‘Packaged’ CRISPR Systems to Standardize novel Biomedical Research
Labiotech UG, All Rights Reserved -
Send this to friend